127 related articles for article (PubMed ID: 29328445)
21. Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer.
Qu H; Xia Y; Li X
Curr Gene Ther; 2020; 20(4):313-320. PubMed ID: 32851960
[TBL] [Abstract][Full Text] [Related]
22. rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy.
Chen GX; Zheng LH; Liu SY; He XH
World J Gastroenterol; 2011 Oct; 17(38):4289-97. PubMed ID: 22090785
[TBL] [Abstract][Full Text] [Related]
23. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
24. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.
Lin H; Xiong W; Zhang X; Liu B; Zhang W; Zhang Y; Cheng J; Huang H
Oncol Rep; 2011 Oct; 26(4):925-30. PubMed ID: 21743969
[TBL] [Abstract][Full Text] [Related]
25. Regulation of apoptosis by Caspases under oxidative stress conditions in mice testicular cells: in vitro molecular mechanism.
Kalia S; Bansal MP
Mol Cell Biochem; 2009 Feb; 322(1-2):43-52. PubMed ID: 18979186
[TBL] [Abstract][Full Text] [Related]
26. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
[TBL] [Abstract][Full Text] [Related]
27. [Adenovirus mediated IL-24 gene expression suppresses gastric cancer cell growth in vitro].
Bao W; Miao J; Sheng W; Shan Y; Li Z; Wang X; Jing Y; Han Y; Yang J
Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1586-92. PubMed ID: 20112706
[TBL] [Abstract][Full Text] [Related]
28. Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.
Deininger MH; Grote E; Wickboldt J; Meyermann R
J Neurooncol; 2000 Jun; 48(2):121-9. PubMed ID: 11083075
[TBL] [Abstract][Full Text] [Related]
29. Anti-cancer effect of combined action of anti-MUC1 and rosmarinic acid in AGS gastric cancer cells.
Radziejewska I; Supruniuk K; Bielawska A
Eur J Pharmacol; 2021 Jul; 902():174119. PubMed ID: 33930385
[TBL] [Abstract][Full Text] [Related]
30. An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.
Yang Y; Xu W; Peng D; Wang H; Zhang X; Wang H; Xiao F; Zhu Y; Ji Y; Gulukota K; Helseth DL; Mangold KA; Sullivan M; Kaul K; Wang E; Prabhakar BS; Li J; Wu X; Wang L; Seth P
Hum Gene Ther; 2019 Sep; 30(9):1117-1132. PubMed ID: 31126191
[TBL] [Abstract][Full Text] [Related]
31. Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.
De la Rosa ÁJ; Rodríguez-Hernández Á; González R; Romero-Brufau S; Navarro-Villarán E; Barrera-Pulido L; Pereira S; Marín LM; López-Bernal F; Álamo JM; Gómez-Bravo MA; Padillo FJ; Muntané J
Gene Ther; 2016 Jan; 23(1):67-77. PubMed ID: 26204498
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
[No Abstract] [Full Text] [Related]
33. Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.
Sayour EJ; McLendon P; McLendon R; De Leon G; Reynolds R; Kresak J; Sampson JH; Mitchell DA
Cancer Immunol Immunother; 2015 Apr; 64(4):419-27. PubMed ID: 25555571
[TBL] [Abstract][Full Text] [Related]
34. The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer.
O'Malley BW; Sewell DA; Li D; Kosai K; Chen SH; Woo SL; Duan L
Mol Endocrinol; 1997 Jun; 11(6):667-73. PubMed ID: 9171230
[TBL] [Abstract][Full Text] [Related]
35. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
[TBL] [Abstract][Full Text] [Related]
36. A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma.
Kim SS; Harford JB; Moghe M; Slaughter T; Doherty C; Chang EH
Int J Cancer; 2019 Nov; 145(9):2535-2546. PubMed ID: 31241175
[TBL] [Abstract][Full Text] [Related]
37. An experimental vaccine expressing wild-type p53 induces protective immunity against glioblastoma cells with high levels of endogenous p53.
Blaszczyk-Thurin M; Ertl IO; Ertl HC
Scand J Immunol; 2002 Oct; 56(4):361-75. PubMed ID: 12234257
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-21 is a critical regulator of CD4 and CD8 T cell survival during priming under Interleukin-2 deprivation conditions.
Khattar M; Miyahara Y; Schroder PM; Xie A; Chen W; Stepkowski SM
PLoS One; 2014; 9(1):e85882. PubMed ID: 24416451
[TBL] [Abstract][Full Text] [Related]
39. Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis.
Murphy ÁC; Weyhenmeyer B; Noonan J; Kilbride SM; Schimansky S; Loh KP; Kögel D; Letai AG; Prehn JH; Murphy BM
Apoptosis; 2014 Apr; 19(4):629-42. PubMed ID: 24213561
[TBL] [Abstract][Full Text] [Related]
40. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.
Kraus JA; Wenghoefer M; Glesmann N; Mohr S; Beck M; Schmidt MC; Schröder R; Berweiler U; Roggendorf W; Diete S; Dietzmann K; Heuser K; Müller B; Fimmers R; von Deimling A; Schlegel U
J Neurooncol; 2001 May; 52(3):263-72. PubMed ID: 11519857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
